Unknown

Dataset Information

0

Novel Aptamers Selected on Living Cells for Specific Recognition of Triple-Negative Breast Cancer.


ABSTRACT: Triple-negative breast cancer (TNBC) is a high heterogeneous group of tumors with a distinctly aggressive nature and high rates of relapse. So far, the lack of any known targetable proteins has not allowed a specific anti-tumor treatment. Therefore, the identification of novel agents for specific TNBC targeting and treatment is desperately needed. Here, by integrating cell-SELEX (Systematic Evolution of Ligands by EXponential enrichment) for the specific recognition of TNBC cells with high-throughput sequencing technology, we identified a panel of 2'-fluoropyrimidine-RNA aptamers binding to TNBC cells and their cisplatin- and doxorubicin-resistant derivatives at low nanomolar affinity. These aptamers distinguish TNBC cells from both non-malignant and non-TNBC breast cancer cells and are able to differentiate TNBC histological specimens. Importantly, they inhibit TNBC cell capacity of growing in vitro as mammospheres, indicating they could also act as anti-tumor agents. Therefore, our newly identified aptamers are a valuable tool for selectively dealing with TNBC.

SUBMITTER: Camorani S 

PROVIDER: S-EPMC7103779 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Novel Aptamers Selected on Living Cells for Specific Recognition of Triple-Negative Breast Cancer.

Camorani Simona S   Granata Ilaria I   Collina Francesca F   Leonetti Francesco F   Cantile Monica M   Botti Gerardo G   Fedele Monica M   Guarracino Mario Rosario MR   Cerchia Laura L  

iScience 20200312 4


Triple-negative breast cancer (TNBC) is a high heterogeneous group of tumors with a distinctly aggressive nature and high rates of relapse. So far, the lack of any known targetable proteins has not allowed a specific anti-tumor treatment. Therefore, the identification of novel agents for specific TNBC targeting and treatment is desperately needed. Here, by integrating cell-SELEX (Systematic Evolution of Ligands by EXponential enrichment) for the specific recognition of TNBC cells with high-throu  ...[more]

Similar Datasets

| S-EPMC8060331 | biostudies-literature
| S-EPMC9024838 | biostudies-literature
| S-EPMC2882502 | biostudies-literature
| S-EPMC6813359 | biostudies-literature
| S-EPMC4764258 | biostudies-literature
| S-EPMC6928780 | biostudies-literature
| S-EPMC7222243 | biostudies-literature
| S-EPMC4791797 | biostudies-other
| S-EPMC5989806 | biostudies-literature
| S-EPMC3319792 | biostudies-literature